查找临床试验
已按「卵巢癌」检索，对应国际通用词 ovarian cancer
共找到 183 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 23:03，每 5 分钟自动同步Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi
China
年龄 18 Years – 75 Years
Chongqing University Cancer Hospital
A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies
China
年龄 18 Years – 75 Years
Sichuan Baili Pharmaceutical Co., Ltd.
A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors
China
年龄 18 Years – 不限
Jacobio Pharmaceuticals Co., Ltd.
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
China
年龄 18 Years – 不限
Peking University First Hospital
A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer
China
年龄 18 Years – 75 Years
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
China、Hong Kong
年龄 18 Years – 不限
The University of Hong Kong
A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration
China
年龄 18 Years – 不限
Peking University Third Hospital
A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
China
年龄 18 Years – 不限
Peking University Third Hospital
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
United States、Argentina、Australia、Belgium、Brazil 等 12 国
年龄 18 Years – 不限
Daiichi Sankyo
RC48 in Combination With AK104 and Bevacizumab in OCCC
China
年龄 18 Years – 75 Years
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Construction of a Multi-dimensional Risk Assessment System: a Clinical Study of Polycystic Ovary Syndrome Complicated With Thrombophilia
China
年龄 14 Years – 45 Years
Guangdong Women and Children Hospital
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
United States、China、Germany、Japan、Netherlands
年龄 18 Years – 不限
Eli Lilly and Company